My migraines are a super power By Harris A. Eyre MD PhD “You may encounter many defeats, but you must not be defeated. In fact, it may be necessary to encounter the defeats so you can know who you are, what you can rise from, and how you can still come out of it.” — […]
My migraines are a super power Read More »
The Access to Care event: Spain Undervalued, underdiagnosed and undertreated.These words aptly describe the reality of a disabling neurological disease that affects over five million people in Spain: migraine. This type of primary headache causes recurring bouts of moderate or intense pain that may be accompanied by nausea, vomiting or extreme sensitivity to light, sound
Access to care: Spain Read More »
The Access to care: Czech Republic event. Migraine is one of the most common neurological diseases. Nevertheless, it is underestimated and still underdiagnosed and undertreated throughout Europe. Patients who struggle with this disease are subsequently limited in their personal and professional lives, which has, among other things, a secondary social and economic impact on them.
Access to care: Czech Republic Read More »
GetImpatientForMigraine campaign is based on the insight that migraine sufferers have to wait 8 years for an effective diagnosis and treatment. The EMHA (European Migraine and Headache Alliance), with the support of Motore Sanità, launched the “Access to Migraine Care Survey” on 16 March 2022 in Rome to support migraine sufferers, as part of the
#GetImpatientForMigraine : Progetto Emicrania 2022 Read More »
EMHA is a full member of EPF since 2011. As the European Patient’s Forum states, members are the backbone of their work. Every single member has contributed and continues to contribute to making EPF the leading voice of patient organisations in Europe. Learn more on all of our partners About EPF The European Patients’ Forum (EPF) is
Migraine in the EU: EMHA’s ‘Access to Care’ survey reveals shocking hurdles for patients to overcome and disparities in the EU. Presented at the Migraine in the EU: Lifting the barriers to treatment webinar. 29 September 2021, Brussels, Belgium. The European Migraine & Headache Alliance (EMHA) organised a webinar “Migraine in the EU: Lifting the
Migraine in the EU: Lifting the barriers to treatment Read More »
EMHA launches the first Migraine Friendly Workplace Stamp. This new initiative is designed to reduce the impact of migraine in the workplaceand recognizes companies that undertake EMHA training as well as making actionablechange in the workplace. Migraine affects over 41 million adults in Europe (prevalence 14%)1 and as migraine peaksduring individuals’ most productive years of
Migraine Friendly Workplace Stamp at work: The stamp that changes it all Read More »
Three awards for the EMHA and The Migraine Movement, led by the EMHA, during this year. The EFNA advocacy awards announced the EMHA and Elena Ruiz de la Torre, executive director of the association, as the 2021 winner. This honorable recognition, puts on the spotlight all the hard work the EMHA has been doing to
Three awards for the EMHA Read More »
The math of migraine: A common denominator.Brett Dabruzzo’s first migraine hit when she was in high school. Pounding headaches and overwhelming nausea weren’t diagnosed as migraine until almost a decade later when Dabruzzo, Pharm.D., director, medical affairs, AbbVie, began working for a pharmaceutical company in its neurology department. A week into her job as a
The math of migraine: news by AbbVie Read More »
Prioritizing the health and wellbeing of those with migraine is in the best interest of everyone, given the impact the disease has on societies and health care systems as a whole. Imagine going through life coping and not living. A life riddled with anxiety and uncertainty where you feel unable to plan the simplest of
Life is meant to be lived, not coped with; just ask those with migraine Read More »
Don't miss out on any updates! Join our community and discover
the latest research, treatments, and events on migraine.
Subscribe now!
